# Cytotoxic T Cells to Prevent Virus Infections

> **NCT01923766** · PHASE1 · COMPLETED · sponsor: **Children's National Research Institute** · enrollment: 10 (actual)

## Conditions studied

- CMV
- EBV
- Adenovirus Infections

## Interventions

- **DRUG:** Cytotoxic T lymphocytes (CTLs).

## Key facts

- **NCT ID:** NCT01923766
- **Lead sponsor:** Children's National Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2020-03-25
- **Final completion:** 2020-03-25
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-07-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01923766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01923766, "Cytotoxic T Cells to Prevent Virus Infections". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01923766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*